Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 58957-92-9 Chemical Structure| 58957-92-9

Structure of Idarubicin
CAS No.: 58957-92-9

Chemical Structure| 58957-92-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Idarubicin is a semisynthetic 4-demethoxy analogue of the antineoplastic anthracycline antibiotic daunorubicin.

Synonyms: 4-Demethoxydaunorubicin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Idarubicin

CAS No. :58957-92-9
Formula : C26H27NO9
M.W : 497.49
SMILES Code : OC(C(C(C1=CC=CC=C21)=O)=C3C2=O)=C4[C@H](C[C@@](C(C)=O)(O)CC4=C3O)O[C@@](O[C@@H](C)[C@H]5O)([H])C[C@@H]5N
Synonyms :
4-Demethoxydaunorubicin
MDL No. :MFCD00866457

Safety of Idarubicin

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H300-H351-H360
Precautionary Statements:P201-P264-P281-P301+P310-P308+P313
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Idarubicin

DNA
Hedgehog

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00651781 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - Spain ... More >> Hospital Germans Trias I Pujol Badalona, Spain Hospital Clinic y Provincial de Barcelona Barcelona, Spain Hospital Santa Creu y Sant Pau.Barcelona Barcelona, Spain Hospital Vall d´hebron Barcelona, Spain Hospital Juan Canalejo La Coruña, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos. Madrid, Spain Hospital Ramón y Cajal. Madrid Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital La Fe de Valencia Valencia, Spain Hospital Lozano Blesa Zaragoza, Spain Less <<
NCT01698879 Novo Acute Myeloid Leukemia Phase 2 Unknown December 2016 Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clinic Barcelona Barcelona, Spain, 08036 Hospital Clinico Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Virgen del Rocio Sevilla, Spain, 41013 Hospital Clínico Universitario de Valencia Valencia, Spain, 496010 Less <<
NCT02310321 Acute Myeloid Leukemia Phase 1 Active, not recruiting April 2020 Japan ... More >> Site JP00003 Aichi, Japan Site JP00001 Fukuoka, Japan Site JP00002 Gunma, Japan Site JP00007 Hyogo, Japan Site JP00006 Kanagawa, Japan Site JP00005 Tokyo, Japan Less <<
NCT02905994 AML Phase 1 Withdrawn(Funding Withdrawn) - United States, Massachusetts ... More >> Massachusetts general Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less <<
NCT01067274 Acute Myeloid Leukemia Phase 3 Withdrawn(Study abandoned) - France ... More >> Chu Amiens Sud Amiens, France, 80054 CH Argenteuil, France, 95107 Hopital Avicenne Bobigny, France Chu Boulogne Sur Mer Boulogne Sur Mer, France, 62321 CH Caen, France, 14033 Hopital Percy Clamart, France, 92141 Ch Sud Francilien Corbeil Essonnes, France, 94010 Hopital Henri Mondor Creteil, France Ch Dunkerque Dunkerque, France, 59385 CH Lens, France, 62307 CHU Lille, France, 59037 CH Limoges, France, 87042 Hopital Edouard Herriot Lyon, France CH Meaux, France, 77104 Centre Antoine Lacassagne Nice, France, 06189 Necker Hospital Paris 15, France, 75015 St Antoine Hospital Paris, France, 75012 Hopital Pitie-Salpetriere Paris, France, 75651 Hopital Saint-Louis Paris, France Ch Rene Dubos Pontoise, France, 95303 CH Roubaix, France, 59100 CHU Rouen, France, 76038 CNLCC Saint-Cloud, France, 92210 CH Valenciennes, France, 59322 CH Versailles, France IGR Villejuif, France Less <<
NCT00876031 Soft Tissue Sarcoma Phase 3 Recruiting July 2024 -
NCT00907582 Acute Promyelocytic Leukemia ... More >> Relapse Less << Phase 2 Terminated(slow recruitment) - China ... More >> Rui Jin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, China, 200025 Less <<
NCT02671708 Autologous Hematopoietic Stem ... More >>Cell Transplantation Acute Myeloid Leukemia Conditioning Less << Phase 2 Phase 3 Recruiting December 2019 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-61641613    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT00003268 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Less << Phase 1 Completed - United States, Pennsylvania ... More >> Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107-5541 Less <<
NCT02873338 Acute Myeloid Leukemia Phase 2 Recruiting November 2018 -
NCT02937662 Acute Myeloid Leukemia Phase 2 Recruiting December 2018 China ... More >> Institute of Hematology & Blood Diseases Hospital Recruiting Tianjin, China Contact: lijun Liu Less <<
NCT01587430 Acute Myeloid Leukemia Phase 4 Unknown January 2015 Russian Federation ... More >> National Research Center for Hematology Moscow, Russian Federation, 125167 Less <<
NCT02560025 Acute Myeloid Leukemia Phase 2 Active, not recruiting October 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02688140 Acute Promyelocytic Leukemia Phase 3 Recruiting January 2022 France ... More >> French-Belgian-Swiss APL study group Not yet recruiting Multiple Locations, France Contact: Pierre Fenaux, Prof. Dr.       pierre.fenaux@avc.ap-hop-paris.fr    Contact: Lionel Ades, Dr.       lionel.ades@sls.aphp.fr    Germany AML-CG study group Recruiting Multiple Locations, Germany Contact: Eva Lengfelder, Prof. Dr.       Eva.Lengfelder@umm.de    AML-SG study group Recruiting Multiple Locations, Germany Contact: Richard F. Schlenk, Prof. Dr.       Richard.Schlenk@uniklinik-ulm.de    OSHO study group Recruiting Multiple Locations, Germany Contact: Dietger Niederwieser, Prof. Dr.       Dietger.Niederwieser@medizin.uni-leipzig.de    SAL study group Recruiting Multiple Locations, Germany Contact: Uwe Platzbecker, Prof. Dr.    +49 351 458 ext 3192    uwe.platzbecker@uniklinikum-dresden.de    Contact: Michaela Sauer    +49 351 458 ext 3192    michaela.sauer@uniklinikum-dresden.de    Italy GIMEMA study group Not yet recruiting Multiple Locations, Italy Contact: Francesco Lo-Coco, Prof. Dr.       Francesco.lo.coco@uniroma2.it    Contact: Fabio Efficace, Dr.       f.efficace@gimema.it    Netherlands HOVON study group Not yet recruiting Multiple Locations, Netherlands Contact: Edo Vellenga, Prof. Dr.       e.vellenga@umcg.nl    Spain PETHEMA study group Not yet recruiting Multiple Locations, Spain Contact: Miguel A. Sanz, Prof. Dr.       sanz_mig@gva.es    Contact: Pau Montesinos, Prof. Dr.       montesinos_pau@gva.es Less <<
NCT02560025 - Active, not recruiting - -
NCT00931138 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> CH Caen, France, 14033 Hopital Percy Clamart, France, 92141 CHU Creteil, France, 94010 CH Lens, France, 62307 CHU Lille, France, 59037 CH Limoges, France, 87042 Hopital Edouard Herriot Lyon, France St Antoine Hospital Paris, France, 75012 Hopital Pitie-Salpetriere Paris, France, 75651 Hopital Saint-Louis Paris, France CH Roubaix, France, 59100 CHU Rouen, France, 76038 CNLCC Saint-Cloud, France, 92210 CH Valenciennes, France, 59322 CH Versailles, France IGR Villejuif, France, 94805 Less <<
NCT02835729 Acute Myeloid Leukemia Phase 1 Recruiting July 2018 United States, Georgia ... More >> Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Sandra Wall, RN    706-721-4430    swall@augusta.edu    Principal Investigator: Jeremy Pantin, MD          United States, Maryland University of Maryland Recruiting Baltimore, Maryland, United States, 21201 Contact: Mohammad Imran, M.D.    410-328-2243    mohammad.imran@umm.edu    Principal Investigator: Ashkan Emadi, M.D., Ph.D.          Johns Hopkins Not yet recruiting Baltimore, Maryland, United States, 21287 Principal Investigator: B. Douglas Smith, MD Less <<
NCT00413166 Acute Promyelocytic Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02416388 Acute Myeloid Leukemia (AML) Phase 2 Phase 3 Recruiting - -
NCT03512197 Acute Myeloid Leukemia (AML) Phase 3 Recruiting April 28, 2026 -
NCT03226418 Adult Acute Myeloid Leukemia ... More >> Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Less << Phase 2 Recruiting July 7, 2023 United States, California ... More >> USC / Norris Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90033 Contact: Mojtaba Akhtari       mojtaba.akhtari@med.usc.edu    Principal Investigator: Mojtaba Akhtari          United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Vijaya R. Bhatt    402-559-8008    vijaya.bhatt@unmc.edu    Principal Investigator: Vijaya R. Bhatt Less <<
NCT00408278 Acute Promyelocytic Leukemia Phase 4 Completed - Poland ... More >> PALG Lodz, Poland Spain Hospital General Albacete, Spain Hospital general Alicante, Spain Hospital germans Trias i Pujol Badalona, Spain Hospital Clinic Barcelona, Spain Hospital de Sant Pau Barcelona, Spain Institut Català d'Oncologái Barcelona, Spain Basurtuko Ospitalea Bilbao, Spain Hospital general Castellon, Spain Hospital de Fuenlabrada Fuenlabrada, Spain Hospital "Dr. Trueta" Gerona, Spain Hospital de Jerez de la Frontera Jerez de la Frontera, Spain Hospital Juan Canalejo La Coruña, Spain Hospital Insular de las Palmas Las Palmas de Gran Canaria, Spain Complejo Hospitalario León Leon, Spain Complexo Hospitalario Xeral-Calde Lugo, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Puerta de Hierro Madrid, Spain Hospital Reina Sofia Madrid, Spain Hospital San Pedro de Alcántara Madrid, Spain Hospital Severo Ochoa Madrid, Spain Hospital Sta. Maria del Rosell Murcia, Spain H. Carlos Haya Málaga, Spain H. Universitario Virgen de la Victoria Málaga, Spain Hospital Central de Asturias Oviedo, Spain Hospital Dr Negrín Palma de Gran Canaria, Spain Hospital de Navarra Pamplona, Spain Hospital de Montecelo Pontevedra, Spain Hospital Clínico Universitario Salamanca, Spain Hospital de Cruces Santander, Spain Hospital de Santiago de Compostela Santiago de Compostela, Spain H.U. Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Dr. Peset Valencia, Spain Hospital general Valencia, Spain Hospital La Fe Valencia, Spain Hospital Clínico de Valladolid Valladolid, Spain Hospital Txagorritxu Vitoria, Spain Hospital Virgen de la Concha Zamora, Spain Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain Uruguay Hospital Maciel Montevideo, Uruguay Less <<
NCT02870010 Localized Non-Resectable Adult... More >> Hepatocellular Carcinoma Less << Phase 1 Completed - France ... More >> CHU de DIJON Dijon, France, 21079 Less <<
NCT00003178 Leukemia Phase 2 Completed - -
NCT00126321 Leukemia, Myelocytic, Acute Phase 2 Unknown March 2011 Germany ... More >> Medical Clinic & Policlinic III, University Bonn Recruiting Bonn, Germany, 53105 Contact: Marie von Lilienfeld-Toal, MD    +49-228-287-22263    m.lilienfeld.toal@uni-bonn.de    Principal Investigator: Marie von Lilienfeld-Toal, MD Less <<
NCT00528450 Leukemia Phase 2 Terminated(Lack of accrual) - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00465933 Acute Promyelocytic Leukemia Phase 4 Completed - Spain ... More >> Basurtuko Ospitalea Basurto, Spain Hospital La Fe de Valencia Valencia, Spain Less <<
NCT02473146 Acute Myeloid Leukemia Phase 2 Phase 3 Recruiting November 2020 France ... More >> C.H.U d'Amiens - Hôpital Sud Recruiting Amiens, France Contact: Bérangère GRUSON          Principal Investigator: Bérangère GRUSON          Hôpital V. Dupouy Recruiting Argenteuil, France Contact: Ahmad AL JIJAKI          Principal Investigator: Ahmad AL JIJAKI, MD          CH Avicenne Recruiting Bobigny, France Contact: Claude GARDIN          Principal Investigator: Claude GARDIN, MD          CHU Caen Recruiting Caen, France Contact: Sylvain CHANTEPIE          Principal Investigator: Sylvain CHANTEPIE, MD          HIA Percy Recruiting Clamart, France, 92140 Contact: Jean-Valère MALFUSON, MD          Principal Investigator: Jean-Valère MALFUSON, MD          Hopital Henri Mondor Recruiting Creteil, France Contact: Cecile PAUTAS          Principal Investigator: Cecile PAUTAS, MD          CHU Dijon Recruiting Dijon, France Contact: Denis CAILLOT          Principal Investigator: Denis CAILLOT, MD          CH Dunkerque Recruiting Dunkerque, France Contact: Iriné Maxime BEMBA          Principal Investigator: Iriné Maxime BEMBA, MD          CH Versailles Recruiting Le Chesnay, France, 78157 Contact: Juliette LAMBERT, MD          Principal Investigator: Juliette LAMBERT, MD          Hôpital Huriez, CHU de Lille Recruiting Lille, France Contact: Bruno QUESNEL          Principal Investigator: Bruno QUESNEL, MD          CHU Limoges Recruiting Limoges, France Contact: Pascal TURLURE          Principal Investigator: Pascal TURLURE, MD          Hôpital de la Conception Active, not recruiting Marseille, France, 13005 Centre Antoine Lacassagne Recruiting Nice, France, 06100 Contact: Lauris GASTAUD, MD          Principal Investigator: Lauris GASTAUD, MD          CHU d'Orléans Recruiting Orléans, France, 45100 Contact: Diana CARP, MD          Principal Investigator: Diana CARP, MD          Hopital Necker Recruiting Paris, France Contact: Olivier HERMINE          Principal Investigator: Olivier HERMINE, MD          Hopital St Louis Recruiting Paris, France Contact: Hervé Dombret, MD          Principal Investigator: Hervé Dombret, MD          Principal Investigator: Pierre FENAUX, MD          Hôpital Saint Antoine Recruiting Paris, France Contact: Ollivier LEGRAND, MD          Principal Investigator: Ollivier LEGRAND, MD          CHU Lyon Sud Recruiting Pierre Benite, France Contact: Xavier THOMAS          Principal Investigator: Xavier THOMAS          Centre H Becquerel Recruiting Rouen, France Contact: Emilie LEMASLE          Principal Investigator: Emilie LEMASLE, MD          Institut de Cancérologie de la Loire Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Emmanuelle TAVERNIER-TARDY, MD          Principal Investigator: Emmanuelle TAVERNIER-TARDY, MD          IGR Not yet recruiting Villejuif, France Contact: Stephane DE BOTTON          Principal Investigator: Stephane DE BOTTON, MD Less <<
NCT00528450 - Terminated(Lack of accrual) - -
NCT00469859 Leukemia Phase 1 Phase 2 Completed - -
NCT00469859 - Completed - -
NCT01242774 Acute Myeloid Leukemia (AML) Phase 1 Completed - United States, California ... More >> Stanford University Medical Center Stanford U Stanford, California, United States, 94304 United States, Massachusetts Dana Farber Cancer Institute Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02115 United States, Ohio Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept.ofJamesCancerHospital Columbus, Ohio, United States, 43210 United States, South Carolina Medical University of South Carolina -Hollings Cancer Center MUSC/HCC (2) Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt 3 Nashville, Tennessee, United States, 37212 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Ulm, Germany, 89081 Spain Novartis Investigative Site Salamanca, Castilla y Leon, Spain, 37007 Novartis Investigative Site Barcelona, Spain, 08025 Less <<
NCT01990807 Childhood Acute Lymphoblastic ... More >>Leukemia Philadelphia Chromosome, Ph^1^, Absent B-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 4 Unknown October 2014 China, Tianjin ... More >> Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Scienses Recruiting Tianjin, Tianjin, China, 300020 Contact: Xiaofan Zhu, MD    +86-22-23909001    xfzhu1981@126.com    Principal Investigator: Xiaofan Zhu, MD Less <<
NCT02135874 Acute Bilineal Leukemia ... More >> Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Mixed Phenotype Acute Leukemia Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified Recurrent Mixed Phenotype Acute Leukemia Less << Phase 2 Recruiting October 30, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-4764       Principal Investigator: Elias Jabbour Less <<
NCT00077116 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - Belgium ... More >> AZ Sint-Jan Brugge, Belgium, 8000 Institut Jules Bordet Brussels, Belgium, 1000 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 H. Hartziekenhuis - Roeselaere. Roeselare, Belgium, 8800 Germany Ruprecht - Karls - Universitaet Heidelberg Heidelberg, Germany, D-69117 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Switzerland Universitaetsspital-Basel Basel, Switzerland, CH-4031 Less <<
NCT00967512 Acute Myelogenous Leukemia Phase 2 Withdrawn(Study Was Terminated... More >> due to lack of Funding.) Less << - -
NCT01132586 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Alkylating Agent-Related Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00107523 Leukemia Phase 1 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00505700 Leukemia Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel/ Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00086099 Leukemia Acut... More >>e Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, California ... More >> Scripps Cancer Center San Diego, California, United States, 92121 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Indiana Cancer Care Center New Albany, Indiana, United States, 47150 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 Spectrum Health Hospitals-Cook Research Dept. (No longer recruiting) Grand Rapids, Michigan, United States, 49503 Great Lakes Cancer Center Management Specialties Grosse Point Woods, Michigan, United States, 48236 Cancer Management Specialists (No longer Recruiting) Grosse Pointe Woods, Michigan, United States, 48236 United States, New Jersey St. Barnabas Health Care Center Newark, New Jersey, United States, 07112 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, North Carolina Wake Forest University School of Medicine Winston-Salem, North Carolina, United States, 27157-1082 United States, Ohio Cleveland Clinic Foundation-Hemoatology/Oncology Cleveland, Ohio, United States, 44195-001 United States, Pennsylvania Thomas Jefferson University Medical College Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Baptist Clinical Research Center Memphis, Tennessee, United States, 38120 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Israel Rambam Medical Center Haifa, Israel, 31096 Rabin Medical Center Petach Tikva, Israel, 49100 Kaplan Med. Center Rehovot, Israel, 76100 Sheba Medical Center Tel Hasomer, Israel, 52620 Less <<
NCT00096122 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01180322 Acute Myeloid Leukemia (AML) Phase 2 Unknown October 2016 Austria ... More >> Universitätsklinikum Innsbruck Innsbruck, Austria, 6020 Krankenhaus der Barmherzigen Schwestern Linz, Austria, 4010 Elisabethinen Krankenhaus Linz Linz, Austria, 4020 Landeskliniken Salzburg Salzburg, Austria, 5020 Hanuschkrankenhaus Wien, Austria, 1140 Germany Universitätsklinikum Charité Berlin Berlin, Germany, 13353 Knappschaftskrankenhaus Bochum-Langendreer Bochum, Germany, 44892 Universitätsklinikum Bonn Bonn, Germany, 53111 Städtisches Klinikum Braunschweig Braunschweig, Germany, 38114 Klinikum Bremen-Mitte Bremen, Germany, 28177 Klinikum Darmstadt Darmstadt, Germany, 64283 Universitätsklinikum Düsseldorf Düsseldorf, Germany, 40225 Kliniken Essen Süd, Evangelischs Krankenhaus Essen, Germany, 45239 Klinikum Esslingen Esslingen, Germany, 73730 Klinikum Frankfurt-Höchst Frankfurt, Germany, 65929 Medizinisches Versorgungszentrum Fulda Fulda, Germany, 36043 Universitätsklinikum Gießen Gießen, Germany, 35392 Wilhelm-Anton-Hospital Goch Goch, Germany, 47574 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Sklepios Klinik Hamburg-Altona Hamburg, Germany, 22763 Evangelisches Krankenhaus Hamm Hamm, Germany, 59063 Klinikum Hanau Hanau, Germany, 63450 KRH Klinikum Hannover-Siloah Hannover, Germany, 30449 Medizinische Hochschule Hannover Hannover, Germany, 30625 SLK-Kliniken Heilbronn Heilbronn, Germany, 74078 Städtisches Klinikum Karlsruhe Karlsruhe, Germany, 76133 Universitätsklinikum Schleswig-Holstein Kiel, Germany, 24116 Caritas-Krankenhaus Lebach Lebach, Germany, 66822 Klinikum Lippe Lemgo, Germany, 32657 Klinikum Lüdenscheid Lüdenscheid, Germany, 58515 Klinikum der Johannes-Guttenberg-Universität Mainz, Germany, 55131 Johannes Wesling Klinikum Minden Minden, Germany, 32429 Stauferklinikum Schwäbisch-Gmünd Mutlangen, Germany, 73557 Klinikum rechts der Isar München, Germany, 81675 Klinikum Passau Passau, Germany, 94032 Krankenhaus der Barmherzigen Brüder Regensburg, Germany, 93049 Caritas-Klinik St. Theresia Saarbrücken, Germany, 66113 Klinikum Stuttgart Stuttgart, Germany, 70174 Diakonie-Klinikum Stuttgart Stuttgart, Germany, 70176 Krankenhaus der Barmherzigen Brüder Trier, Germany, 54292 Universitätsklinikum Tübingen Tübingen, Germany, 72076 Universitätsklinikum Ulm Ulm, Germany, 89081 Schwarzwald-Baar-Klinikum Villingen-Schwenningen, Germany, 78050 Helios Klinikum Wuppertal, Germany, 42283 Less <<
NCT00093483 Leukemia Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01484171 Acute Myeloid Leukemia Phase 3 Unknown December 2017 China, Beijing ... More >> The Affiliated Hospital of the Chinese Academy of Military Medical Science Recruiting Beijing, Beijing, China, 100071 Contact: huisheng ai, M.D.    86-01-66947126    huishengai@163.com    Contact: zheng dong, M.M    86-01-66947130    dongz1983@139.com Less <<
NCT00096122 - Completed - -
NCT01876953 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00620321 Acute Myeloid Leukemia Phase 2 Completed - United States, Michigan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ann Arbor, Michigan, United States, 48105 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States, 77030 Less <<
NCT00801489 Acute Myeloid Leukemia With In... More >>v(16)(p13.1q22); CBFB-MYH11 Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Inv(16) Myelodysplastic Syndrome With Excess Blasts t(16;16) t(8;21) Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Recruiting April 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Gautam Borthakur    713-563-1586       Principal Investigator: Gautam Borthakur Less <<
NCT02028949 Unresectable Non-metastatic He... More >>patocellular Carcinoma Child A/B7 Cirrhosis Less << Phase 1 Completed - France ... More >> CHU de Dijon Dijon, France, 21079 Cedex Less <<
NCT00838240 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Phase 2 Unknown - Belgium ... More >> A.Z. Sint-Jan Recruiting Brugge, Belgium Principal Investigator: Dominik Selleslag          Institut Jules Bordet Not yet recruiting Brussel, Belgium Principal Investigator: Dominique Bron          CHU Sart-Tilman Not yet recruiting Liège, Belgium Principal Investigator: Frédéric Baron          Croatia University Hospital Rebro Not yet recruiting Zagreb, Croatia Principal Investigator: Boris Labar          France Hôpital Saint Antoine AP-HP Not yet recruiting Paris, France Principal Investigator: Olivier Legrand          Italy Azienda Ospedallera Universitaria - Policlinico Tor Vergata Recruiting Roma, Italy Principal Investigator: Sergio Amadori          Univesita Degli Studi "La Sapienza" Recruiting Roma, Italy Principal Investigator: Giovanna Meloni          Netherlands Leiden University Medical Center Active, not recruiting Leiden, Netherlands Radboud University Nijmegen Medical Center Recruiting Nijmegen, Netherlands Principal Investigator: Petra Muus          Jeroen Bosch Ziekenhuis Recruiting s' Hertogenbosch, Netherlands Principal Investigator: Hans Pruijt Less <<
NCT00067028 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Chronic Myeloid Leukemia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01873807 Acute Lymphoblastic Leukemia Phase 4 Unknown December 2015 China, Fujian ... More >> Department of Hematology, Union Hospital of Fujian Medical University Recruiting Fuzhou, Fujian, China Contact: Jianda Hu, MD          Principal Investigator: Jianda Hu, MD          China, Guangdong Guangzhou General Hospital of Guangzhou Military Command Recruiting Guangzhou, Guangdong, China, 510010 Contact: Yang Xiao, MD       jdxiao111@163.com    Principal Investigator: Yang Xiao, MD          Guangdong General Hospital Recruiting Guangzhou, Guangdong, China, 510030 Contact: Suijin Wu, MD       songwu55555@163.com    Principal Investigator: Suijin Wu, MD          Guangdong No.2 Provincial People's Hospital Recruiting Guangzhou, Guangdong, China, 510317 Contact: Qing Zhang, MD       zhqing@vip.163.com    Principal Investigator: Qing Zhang, MD          Department of Hematology, Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou, MD PhD    86-20-62787883    hanson2008@gmail.com    Contact: Qifa Liu, MD    86-20-61641612    liuqifa628@163.com    Sub-Investigator: Hongsheng Zhou, MD PhD          Third Affiliated Hospital, Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Dongjun Lin, MD       lindongjun0168@163.com    Principal Investigator: Dongjun Lin, MD          Department of Hematology, 1st Guangzhou People Hospital Recruiting Guangzhou, Guangdong, China Contact: Shunqing Wang, MD          Principal Investigator: Shunqing Wang, MD          Oncology-Hematology Center, 1st Affiliated Hospital, Guangzhou Medical Collgege Recruiting Guangzhou, Guangdong, China Contact: Huo Tan, MD PhD          Principal Investigator: Huo Tan, MD PhD          Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China Contact: Yuhua Li, MD PhD       li_yuhua@yahoo.com    Principal Investigator: Yuhua Li, MD PhD          Zhongshan People Hospital,Guangdong Recruiting Zhongshan, Guangdong, China, 528403 Contact: Xiaojun Xu, MD       doctorxu@163.com    Principal Investigator: Xiaojun Xu, MD          China, Guangxi Department of Hematology, 1st Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 530021 Contact: Yongrong Lai, MD          Principal Investigator: Yongrong Lai, MD          China, Hubei Department of Hematology, Union Hospital, Huazhong Science and Technology Recruiting Wuhan, Hubei, China, 430022 Contact: Yu Hu, MD PhD          Principal Investigator: Yu Hu, MD PhD          Department of Hematology, Tongji Hospital, Huazhong Science and Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Jianfeng Zhou, MD PhD       jfzhou@tjh.tjmu.edu.cn    Principal Investigator: Jianfeng Zhou, MD PhD Less <<
NCT00193973 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Completed - Australia, Australian Capital ... More >>Territory The Canberra Hospital Garran, Australian Capital Territory, Australia, 2605 Australia, New South Wales Calvary Mater Newcastle Newcastle, New South Wales, Australia, 2298 Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Westmead Hospital Wentworthville, New South Wales, Australia, 2145 Illawarra Cancer Care Centre Wollongong, New South Wales, Australia Australia, Queensland Royal Brisbane Hospital Herston, Queensland, Australia, 4029 Mater QRI South Brisbane, Queensland, Australia, 4101 Premion - Tugun Tugun, Queensland, Australia, 4224 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Andrew Love Cancer Centre, Geelong Hospital Geelong, Victoria, Australia, 3220 Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 8006 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 New Zealand Auckland Hospital Auckland, New Zealand, 1001 Christchurch Hospital Christchurch, New Zealand, 4710 Less <<
NCT02115295 Leukemia Phase 2 Recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01802333 Acute Myeloid Leukemia ... More >> Untreated Adult Acute Myeloid Leukemia Less << Phase 3 Completed - -
NCT02249091 Acute Myeloid Leukemia (Relaps... More >>ed/Refractory) Less << Phase 2 Active, not recruiting June 2018 Germany ... More >> Universitätsklinikum Frankfurt Frankfurt am Main, Hessen, Germany, 60590 Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Less <<
NCT03444649 AML Phase 1 Withdrawn(IMP will not be furt... More >>her developed) Less << October 2019 Switzerland ... More >> Departement of Medical Oncology, University Hospital Berne Berne, Switzerland, 3010 Less <<
NCT01958996 High Grade Lymphomas CD20 Posi... More >>tive Less << Phase 1 Phase 2 Completed - France ... More >> CHU de Poitiers Poitiers, France, 86000 Less <<
NCT01766375 Acute Myeloid Leukemia Phase 3 Unknown June 2016 China, Guangxi ... More >> First Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 530021 Contact: Lai Yongrong, doctor    0086-13517711828    laiyongrong@263.net    Contact: Zhang Zhongming, doctor    0086-15807801369    zzmmissyou@126.com    Principal Investigator: Lai Yongrong, doctor          Sub-Investigator: Zhang Zhongming, doctor          Sub-Investigator: Li Qiaochuan, doctor Less <<
NCT00210366 Lymphoma, B-Cell Phase 2 Terminated(due to slow accrual... More >>) Less << - Italy ... More >> Servizio Radiochemioterapia - Ospedale San Raffaele Milan, Italy, 20132 Less <<
NCT00023920 Blastic Phase Chronic Myelogen... More >>ous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Less << Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01247493 Acute Myeloid Leukemia Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00840346 Acute Myeloblastic Leukaemia Phase 1 Phase 2 Completed - Spain ... More >> Hospital Clinic y Provincial de Barcelona Barcelona, Spain Hospital Germans Trías i Pujol Barcelona, Spain Hospital Santa Creu y Sant Pau. Barcelona Barcelona, Spain Hospital 12 de Octubre. Madrid Madrid, Spain Hospital Clínico San Carlos. Madrid Madrid, Spain Hospital Ramón y Cajal. Madrid Madrid, Spain Hospital Morales Messeguer. Murcia Murcia, Spain Hospital Univ. La Fe de Valencia Valencia, Spain Hospital Lozano Blesa. Zaragoza Zaragoza, Spain Less <<
NCT01145846 Acute Myelogenous Leukemia Phase 3 Unknown April 2014 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 138-736 Contact: Ye Eun Jang, nurse    82-2-3010-6378    redpin75@paran.com Less <<
NCT01039363 Acute Myeloid Leukemia Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 135-710 Principal Investigator: Dong Hwan Won, M.D.,Ph.D. Less <<
NCT01018069 Leukemia Phase 2 Terminated(Failed to reach end... More >>points) Less << - United States, California ... More >> UCLA School of Medicine Los Angeles, California, United States, 90095 United States, Colorado Rocky Mountain Blood & Marrow Transplant Program Denver, Colorado, United States, 80218 United States, Illinois Northwestern University Med School, div. Oncology & Hematology Chicago, Illinois, United States, 60611 United States, New York New York Medical College Valhalla, New York, United States, 10595 United States, Texas MD Anderson Cancer Center University of Texas Houston, Texas, United States, 77303 Cancer Research Institute of Scott & White Hospital Temple, Texas, United States, 76502 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada Canada, Quebec Hopital Charles Lemoyne Greenfield Park, Quebec, Canada, J4V 2H1 Hopital Maisonneuve-Rosemont Montreal, Quebec, Canada Hopital Sacre Coeur Montreal, Quebec, Canada Germany Klinikum Chemnitz gGmbH Chemnitz, Germany, 09113 St. Johannes Hospital Duisburg, Germany, 47166 Universitatsklinimum Essen Essen, Germany, 45147 Universitatsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 2. Medizinische Klinik und Poliklinik im Stadtischen Krankenhaus Kile GmgH Kiel, Germany, 24116 III. Medizinische Klinik und Poliklinik der Johannes Gutenberg-Universitat Mainz, Germany, 55131 Medizinische Klinik a Hamatologie und Onkologie Munster, Germany, 48129 Robert Boasch Krankenhaus Stuttgart Stuttgart, Germany, 70376 Less <<
NCT00124813 Multiple Myeloma Phase 2 Unknown November 2010 Germany ... More >> Medical Clinic & Policlinic III, University of Bonn Recruiting Bonn, Germany, 53105 Contact: Ingo Schmidt-Wolf, MD    +49-228-287-15507    picasso@uni-bonn.de    Principal Investigator: Ingo Schmidt-Wolf, MD Less <<
NCT00831766 Myelodysplastic Syndrome ... More >> Acute Myeloid Leukemia Less << Phase 1 Phase 2 Active, not recruiting February 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Ohio Cleveland Clinic - Taussig Cancer Institute Cleveland, Ohio, United States, 44195 Less <<
NCT00096148 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Childhood Acute Basophilic Leukemia Childhood Acute Eosinophilic Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00831766 - Active, not recruiting - -
NCT00542971 - Completed - -
NCT00331513 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Promyelocytic Leukemia (M3) Blastic Phase Chronic Myelogenous Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01141725 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q) Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00656617 Acute Myeloid Leukemia (AML) ... More >> Myelodysplastic Syndrome (MDS) Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00840177 Leukemia Phase 2 Active, not recruiting July 2019 -
NCT01141725 - Completed - -
NCT00542971 AML Acute Mye... More >>loid Leukemia Myelodysplastic Disorders Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00656617 - Completed - -
NCT01889407 - Unknown July 2016 China, Guangdong ... More >> Bing Xu Recruiting GuangZhou, Guangdong, China, 510515 Contact: Bing Xu, M.D    13189096353    xubingzhangjian@126.com    Contact: Xutao Guo, M.D    13802426709    gxt827@126.com    Principal Investigator: Bing Xu, M.D Less <<
NCT01831232 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Refractory Anemia With Excess Blasts Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01831232 - Completed - -
NCT02049801 Adult Acute Minimally Differen... More >>tiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Terminated(logistics) - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT02277847 Acute Myeloid Leukemia Phase 4 Unknown June 2017 -
NCT01692197 Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00382954 Acute Myelogenous Leukemia Phase 1 Completed - United States, Kentucky ... More >> University of Kentucky Lexington, Kentucky, United States, 40536 United States, New York University of Rochester Rochester, New York, United States, 14642 Less <<
NCT02464657 Leukemia Acut... More >>e Myeloid Leukemia Myelodysplastic Syndrome Less << Phase 1 Phase 2 Recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02185768 Liver Cancer Phase 2 Completed - France ... More >> CHU Amiens Amiens, France CHU d'ANGERS Angers, France, 49933 CHU - Hôpital François Mitterand Dijon, France, 21079 Hôpital La Croix Rousse Lyon, France, 69317 Hôpital Edouard Herriot Lyon, France, 69437 CHU St Eloi Montpellier, France, 34295 Hôpital de l'Archet II Nice, France, 06202 Less <<
NCT01607645 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Less << Phase 2 Terminated(The study was termi... More >>nated early because there were other competing protocols.) Less << - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01607645 - Terminated(The study was termi... More >>nated early because there were other competing protocols.) Less << - -
NCT03330821 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia With Myelodysplasia-Related Changes Therapy-Related Acute Myeloid Leukemia Less << Phase 1 Phase 2 Recruiting April 18, 2021 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Donna Fernando, RN    323-409-4388    donna.fernando@med.usc.edu    Contact: Christine Duran    323-865-0371    duran_c@med.usc.edu    Principal Investigator: Kevin R. Kelly, MD Less <<
NCT01692197 - Completed - -
NCT01025154 Acute Myeloid Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00878722 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - France ... More >> CHU Lapeyronie Montpellier, France, 34295 Hôpital St. Louis Paris, France, 75475 Germany Uniklinik Homburg Homburg, Germany, 66424 Uni Hospital Marburg Marburg, Germany, 35043 Universitätsklinikum Ulm Ulm, Germany, 89081 United Kingdom Christie Hospital NHS Trust Manchester, United Kingdom, M20 4BX Less <<
NCT01025154 - Completed - -
NCT01794702 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01822015 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Untreated Adult Acute Myeloid Leukemia Less << Early Phase 1 Active, not recruiting June 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00074737 Acute Myelogenous Leukemia Phase 2 Completed - United States, California ... More >> University of California, San Diego La Jolla, California, United States, 92093-0960 United States, Florida University of Miami Health Center Miami, Florida, United States, 33136 United States, Missouri Washington University Medical Center (Siteman Cancer Center) St. Louis, Missouri, United States, 63110 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 North Shore University Hospital Lake Success, New York, United States, 11041 United States, Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03349957 - Completed - France ... More >> Uhmontpellier Montpellier, France, 34295 Less <<
NCT00528398 Leukemia Phase 2 Completed - United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00528398 - Completed - -
NCT00422591 Leukemia Acut... More >>e Myeloid Leukemia AML Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00878722 - Completed - -
NCT01040559 Carcinoma, Hepatocellular Phase 1 Completed - France ... More >> Centre Hospitalier Universitaire de DIJON Dijon, Burgundy, France, 21000 Less <<
NCT02440568 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting May 5, 2019 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: John G Quigley, MD    312-413-1300    seanq@uic.edu    Contact: Stephanie Barath, BS    (312) 355-5767    sbarat2@uic.edu Less <<
NCT01035502 Acute Myeloid Leukemia Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 France CHU Lyon, Hospital Edouard Herriot Lyon, France, 69437 Institut Paoli-Calmettes Marseille, France, 13273 CHU Toulouse, Hospital Purpan Toulouse, France, 31059 Germany Charite University Hospital Benjamin Franklin Berlin, Germany, 12200 Universitätsklinikum Münster Münster, Germany Universitätsklinikum Ulm Ulm, Germany, D-89081 Norway Haukeland University Hospital Bergen, Norway Less <<
NCT03727633 Carcinoma, Hepatocellular Phase 2 Recruiting June 2021 France ... More >> CHU d'Angers Not yet recruiting Angers, France, 49933 Contact: Christophe AUBE, PH          CHU de Dijon Not yet recruiting Dijon, France, 21079 Contact: Romaric LOFFROY, PH          CHU de Montpellier Recruiting Montpellier, France, 34295 Contact: Boris GUIU, PUPH          CHU de Nice Not yet recruiting Nice, France, 06202 Contact: Patrick CHEVALLIER, PH Less <<
NCT01534702 Acute Myeloid Leukemia Phase 1 Phase 2 Unknown September 2015 Germany ... More >> Universitätsklinikum Düsseldorf Not yet recruiting Düsseldorf, Germany, 40225 Contact: Andrea Kuendgen, MD       andrea.kuendgen@med.uni-duesseldorf.de    Principal Investigator: Andrea Kuendgen, MD          Klinikum Essen-Werden Recruiting Essen, Germany, 45239 Contact: Mohammad Wattad, MD       m.wattad@kliniken-essen-sued.de    Principal Investigator: Mohammad Wattad, MD          Universitätsklinikum Freiburg Recruiting Freiburg, Germany, D-79106 Contact: Michael Luebbert, MD       luebbert@mm11.ukl.uni-freiburg.de    Principal Investigator: Michael Luebbert, MD          Universitätsklinikum Hamburg-Eppendorf Not yet recruiting Hamburg, Germany, 20246 Contact: Walter Fiedler, MD       fiedler@uke.uni-hamburg.de    Principal Investigator: Walter Fiedler, MD          Hannover Medical School Recruiting Hannover, Germany, D-30625 Contact: Juergen Krauter, MD    +49-511-532-3720    Krauter.Juergen@MH-Hannover.de    Principal Investigator: Juergen Krauter, MD          Klinikum Rechts der Isar Not yet recruiting Muenchen, Germany, 81675 Contact: Justus Duyster       justus.duyster@lrz.tum.de    Principal Investigator: Justus Duyster, MD          Universitätsklinikum Ulm Not yet recruiting Ulm, Germany, 89081 Contact: Richard Schlenk, MD       Richard.Schlenk@uniklinik-ulm.de    Principal Investigator: Richard Schlenk, MD Less <<
NCT00422591 - Completed - -
NCT02096055 Leukemia Phase 2 Active, not recruiting April 2026 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01289457 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01700413 Di Novo Acute Myeloid Leukemia Phase 2 Completed - Spain ... More >> Hospital Universitari Germans Trias I Pujol de Badalona Badalona, Spain, 08916 Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08025 Hospitals Vall D'Hebron Barcelona, Spain, 08035 Hospital Clinic I Provincial de Barcelona Barcelona, Spain, 08036 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT01305135 High Grade Myelodysplastic Syn... More >>drome Lesions Less << Phase 1 Phase 2 Completed - France ... More >> CHU de Haut-Lévèque Pessac, Bordeaux - Pessac, France, 33604 CHU d'Amiens Amiens, France, 80054 CHU d'Angers Angers, France, 49033 Hôpital de la cote basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 CHRU de Caen - Hôpital Côte de Nacre Caen, France, 14033 CHU Estaing Clermont-Ferrand, France, 63000 CHU Dijon Hôpital d'enfants Dijon, France, 21000 CHU Albert Michallon Grenoble, France, 38043 CH Le Mans Le Mans, France, 72000 CHU de Limoges Limoges, France, 87042 Centre Hospitalier Lyon Sud Lyon, France, 69495 Institut Paoli-Calmette Marseille, France, 13009 CHU Brabois Nancy, France, 54511 CHU Hotel dieu Nantes, France, 44093 CHU NICE, Hôpital l'Archet Nice, France, 06202 Hôpital saint louis - Hématologie Clinique Paris, France, 75010 Hôpital Saint Louis - Hématologie Séniors Paris, France, 75010 Hôpital Saint Antoine Paris, France, 75012 Hôpital cochin Paris, France, 75014 Centre hospitalier Joffre Perpignan, France, 66046 CHU de Poitiers Poitiers, France, 86021 CH de Périgueux Périgueux, France, 24019 Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Hôpital Hautepierre Strasbourg, France, 67098 Hôpital PURPAN - Hématologie Clinique Toulouse, France, 31059 Hôpital Purpan - Médecine Interne Toulouse, France, 31059 Hôpital Bretonneau Tours, France, 37000 CH de Valence Valence, France, 26953 Institut Gustave Roussy Villejuif, France, 94805 Tunisia Hôpital Aziza Othmana Tunis, Tunisia Less <<
NCT02635074 Recurrent Adult Acute Myeloid ... More >>Leukemia Less << Phase 1 Terminated(safety) - United States, California ... More >> Stanford University, School of Medicine Palo Alto, California, United States, 94304 Less <<
NCT02652871 Leukemia Phase 1 Recruiting May 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01518556 Leukemia, Myeloid, Acute Phase 1 Phase 2 Recruiting December 2019 Korea, Republic of ... More >> Division of Hematology-Oncology, Konkuk University Medical Center Recruiting Seoul, Korea, Republic of, 143-729 Contact: Mark H Lee, M.D., Ph.D.    +82-10-5035-7410    mlee@kuh.ac.kr    Contact: Jina Park, R.N.    +82-2-2030-6537    rachel12055@naver.com    Principal Investigator: Mark H Lee, M.D., Ph.D. Less <<
NCT03446638 Myelodysplastic Syndromes Not Applicable Not yet recruiting September 2022 United States, Florida ... More >> University of Florida Not yet recruiting Gainesville, Florida, United States, 32608 Less <<
NCT00378365 Leukemia, Promyelocytic, Acute Phase 3 Unknown September 2016 France ... More >> Chu Avicenne Recruiting Bobigny, France, 93000 Contact: Lionel ADES, MD,PhD    +33(0)- 148 95 70 55    Lionel.ades@avc.aphp.fr    Principal Investigator: Lionel ADES, MD Less <<
NCT02272478 Acute Myeloid Leukaemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Phase 3 Recruiting October 2020 United Kingdom ... More >> UHW Recruiting Cardiff, United Kingdom, CF14 4XN Principal Investigator: Steve Knapper          Nottingham University Hospital Recruiting Nottingham, United Kingdom Contact: Nigel Russell, MD Less <<
NCT00002658 Leukemia Neut... More >>ropenia Less << Phase 3 Unknown - United Kingdom ... More >> University of Wales College of Medicine Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT03165851 - Completed - China, Tianjin ... More >> InstituteHBDH Tianjin, Tianjin, China, 300020 Less <<
NCT00002868 Leukemia Phase 3 Completed - United States, New Jersey ... More >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States, 07701 United Kingdom Royal Infirmary Glasgow, Scotland, United Kingdom, G4 0SF Less <<
NCT00002549 Leukemia Phase 3 Unknown - -
NCT00002532 Leukemia Phase 2 Unknown - Germany ... More >> Medizinische Hochschule Hannover Hannover, Germany, D-30625 Less <<
NCT00198991 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)69 6301 5194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)69 6301 6365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT00002517 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Hospitalier Regional de Lille Lille, France, 59037 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34295 CHR Hotel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hopital Robert Debre Paris, France, 75019 Institut Curie - Section Medicale Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants (Purpan Enfants) Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Less <<
NCT00002761 Leukemia Phase 1 Phase 2 Withdrawn(PI left institution) - -
NCT00317408 Lymphoma Not Applicable Unknown - -
NCT00199186 Philadelphia Positive Acute Ly... More >>mphoblastic Leukemia Lymphoid Blastic Phase of Chronic Myeloid Leukemia Less << Phase 2 Unknown - Germany ... More >> Medizinische Klinik II, Johann Wolfgang Goethe Universität Recruiting Frankfurt/Main, Germany, 60590 Contact: Oliver G Ottmann, M.D.    ++49-69-6301-0 ext 6221    ottmann@em.uni-frankfurt.de Less <<
NCT00005823 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2RR University College Hospital London, England, United Kingdom, WC1E 6AU University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT00198978 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)6963015194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)6963016365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT00458848 Leukemia Phase 2 Completed - -
NCT00002771 Leukemia Phase 3 Unknown - Germany ... More >> III Medizinische Klinik Mannheim Mannheim, Germany, D-68135 Less <<
NCT00004905 Leukemia Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT00199056 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00187083 Acute Lymphoblastic Leukemia Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00002719 Leukemia Neut... More >>ropenia Less << Phase 3 Completed - Italy ... More >> Azienda Policlinico Umberto Primo Rome, Italy, 00161 Less <<
NCT00004878 Graft Versus Host Disease ... More >> Leukemia Less << Phase 2 Withdrawn(study never opened) - -
NCT00199095 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT02844530 CD22+ Relapsed/Refractory B-AL... More >>L Less << Phase 2 Withdrawn - France ... More >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63000 Less <<
NCT03250338 Relapsed/Refractory Acute Myel... More >>oid Leukemia With FLT3 Activating Mutations Less << Phase 3 Recruiting October 2021 United States, California ... More >> UC Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Brian Jonas, MD    916-734-5959       United States, Kansas Kansas University Recruiting Kansas City, Kansas, United States, 666160 Contact: Sunil Abhyankar, MD          Principal Investigator: Sunil Abhyankar, MD          United States, Michigan Karmanos Cancer Center Recruiting Detroit, Michigan, United States, 48201 Contact: Jay Yang, MD       yangj@karmanos.org    Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Yue Guo, MD          Principal Investigator: Yue Guo, MD          United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Eunice Wang, MD          Principal Investigator: Eunice Wang, MD Less <<
NCT00405743 Hematologic Malignancies ... More >> AML Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Mew York Medical College, Division of Oncology Valhalla, New York, United States, 10595 United States, North Carolina Duke University Medical Center (DUMC) Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Institute for Drug Development (IDD), Cancer Therapy and Research Center, 7979 Wurzbach Rd. San Antonio, Texas, United States, 78229 France Hematology Service, Hôpital Beaujon and Hôpital Avicenne Bobigny, Paris, France, 93009 Centre Hospitalier Universitaire, CHU de Lyon, Service d'Hematologie Clinique Lyon, France, 69437 Institut Paoli-Calmettes Marseille, France, 13273 Centre Hospitalier Universitaire CHU de Toulouse, Hopital Purpan Toulouse, France, 40031-31059 Germany University Hospital Benjamin Franklin Med.Clinic III Berlin, Germany, 12200 Department of Internal Medicine Klinikum der Johann Wolfgang Goethe-Universität Medizinische Klinik II Frankfurt am Main, Germany, 60590 Westfälische Wilhelms-Universität Münster Medizinische Klinik und Polikinik Innere Medizin A Münster, Germany, 48129 Italy Institute of Hematology & Medical Oncology L and A Serágnoli University of Bologna Bologna, Italy, 40138 Universitá degli Studi di Roma Ematologia- Policlinico Tor Vergata Rome, Italy, 00133 Norway Department of Hematology, Ullevål University Hospital, University of Oslo Oslo, Norway, 0407 United Kingdom Christie Hospital Manchester, United Kingdom, M20 4BX Less <<
NCT02907359 Myelodysplastic Syndromes ... More >> Leukemia, Myelomonocytic, Chronic Less << Phase 3 Recruiting December 2019 -
NCT02665065 Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << Phase 3 Recruiting June 2020 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less <<
NCT02881086 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 3 Recruiting June 2025 Germany ... More >> University Hospital of Frankfurt (Main) Recruiting Frankfurt (Main), Germany, 60590 Less <<
NCT00866918 - Completed - -
NCT00071799 - Completed - -
NCT00071799 Myelodysplastic Syndromes Phase 3 Completed - -
NCT01723657 Leukemia, Myelocytic, Acute Phase 2 Completed - Spain ... More >> Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 ICO Hospital Universitari de Bellvitge L'Hospitalet del Llobregat, Barcelona, Spain, 08907 Hospital A Coruña A Coruña, Coruña, Spain, 15006 Hospital Universitari Son Espases Palma de Mallorca, Mallorca, Spain, 07198 Hospital Universitari Son Dureta Palma de Mallorca, Mallorca, Spain Hospital Verge de la Cinta Tortosa, Tarragona, Spain, 43517 Hospital del Mar Barcelona, Spain, 08003 Centro Medico Teknon Barcelona, Spain, 08022 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Vall d'Hebron Barcelona, Spain, 08035 Hospital Clínic de Barcelona Barcelona, Spain, 08036 Hopital Universitari de Girona Dr. Josep Trueta Girona, Spain, 17007 Hospital Universitari Arnau de Vilanova Lleida, Spain, 25006 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario Virgen de la Victoria Malaga, Spain, 29010 Hospital General Universitario de Murcia Murcia, Spain, 30008 Hospital Universitario Virgen del Rocio Sevilla, Spain, 41014 Hospital Universitari Joan XXIII Tarragona, Spain, 43007 Mutua de Terrassa Terrassa, Spain, 08225 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Hospital Universitario Rio Hortega Valladolid, Spain, 41010 Less <<
NCT00209833 De Novo Akute Myeloid Leukemia... More >> (AML) Secondary Acute Myeloid Leukemia (AML) Refractory Anemia With Excess of Blasts in Transformation Less << Phase 2 Phase 3 Unknown - Germany ... More >> Hannover Medical School Hannover, Germany, 30625 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00866918 Childhood Acute Promyelocytic ... More >>Leukemia (M3) Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - -
NCT02039726 AML Phase 3 Active, not recruiting July 2019 -
NCT00003783 Leukemia Phase 2 Completed - -
NCT02029950 Acute Myeloid Leukemia ... More >> Blasts 5-19 Percent of Peripheral Blood White Cells Blasts More Than 10 Percent of Bone Marrow Nucleated Cells Chronic Myelomonocytic Leukemia-2 High Risk Myelodysplastic Syndrome Myeloproliferative Neoplasm Previously Treated Myelodysplastic Syndrome Less << Phase 1 Active, not recruiting - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06520 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT02339740 Acute Promyelocytic Leukemia W... More >>ith PML-RARA Less << Phase 3 Recruiting - -
NCT03760445 Leukemia, Myeloid, Acute Phase 1 Phase 2 Not yet recruiting October 13, 2022 -
NCT00002835 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT02013167 Relapsed/Refractory B-precurso... More >>r Acute Lymphoblastic Leukemia Less << Phase 3 Terminated - -
NCT00909168 Acute Myeloid Leukemia Phase 2 Phase 3 Completed - Italy ... More >> University Hospital, Udine Udine, Italy, 33100 Less <<
NCT03117751 Acute Lymphoblastic Leukemia ... More >> Acute Lymphoblastic Lymphoma Less << Phase 2 Phase 3 Recruiting March 31, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Hiroto Inaba, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Hiroto Inaba, MD, PhD Less <<
NCT00002812 Leukemia Phase 3 Completed - -
NCT02013167 - Terminated - -
NCT00893399 Acute Myeloid Leukemia Phase 3 Active, not recruiting July 2020 -
NCT00052299 Leukemia Phase 3 Completed - -
NCT03560908 Relapsed AML ... More >>T(8;21) C-KIT Mutation Less << Phase 1 Recruiting December 31, 2020 China, Tianjin ... More >> HBDH Recruiting Tianjin, Tianjin, China, 300020 Contact: Hui Wei Less <<
NCT00006122 Leukemia Phase 2 Completed - Austria ... More >> Innsbruck Universitaetsklinik Innsbruck, Austria, A-6020 Belgium A.Z. St. Jan Brugge, Belgium, 8000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 CHU Sart-Tilman Liege, Belgium, B-4000 Croatia University Hospital Rebro Zagreb, Croatia, 41000 France Hopital Edouard Herriot Lyon, France, 69437 Hotel Dieu de Paris Paris, France, 75181 Hopital Necker Paris, France, 75743 Germany Medizinische Klinik und Poliklinik Heidelberg, Germany, D-69115 Eberhard Karls Universitaet Tuebingen, Germany, D-72076 Italy Ospedale Generale Regionale Bolzano, Italy, 39100 Ospedali Riuniti Reggio Calabria, Italy, 89100 Ospedale San Eugenio Rome, Italy, 00144 Azienda Policlinico Umberto Primo Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 Netherlands Groot Ziekengasthuis 's-Hertogenbosch 's-Hertogenbosch, Netherlands, 5211 NL Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Less <<
NCT03558607 Secondary Acute Myelogenous Le... More >>ukemia Evolving From Myeloproliferative Disorder Less << Phase 1 Phase 2 Recruiting December 31, 2021 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 13620 Contact: Ryul Kim, Dr    +82 10 9412 6108    chrono0707@icloud.com    Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Ryul Kim, MD    +82 10 9412 6108    chrono0707@icloud.com    Principal Investigator: Youngil Koh, MD          Sub-Investigator: Sung soo Yoon, MD, PhD          Sub-Investigator: In ho Kim, MD          Sub-Investigator: Ryul Kim, MD Less <<
NCT01191541 Leukemia Not Applicable Unknown December 2018 China ... More >> Department of Pediatrics, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, PR China Recruiting Tianjin, China, 300020 Contact: Xiaofan Zhu, MD    +86 22 23909001    zhuxiaof@yahoo.com.cn    Principal Investigator: xiaofan Zhu, MD Less <<
NCT00002798 Childhood Acute Erythroleukemi... More >>a (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT02172872 Acute Myeloid Leukemia (AML) Phase 3 Recruiting December 2019 -
NCT03564470 Leukemia Leuk... More >>emia, Acute Leukemia, Lymphoblastic Leukemia, B-cell Less << Phase 2 Phase 3 Recruiting August 30, 2020 China, Guangdong ... More >> Department of Hematology, Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou, PhD, MD    86-20-62787349    zhs1@i.smu.edu.cn Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.01mL

0.40mL

0.20mL

10.05mL

2.01mL

1.00mL

20.10mL

4.02mL

2.01mL

References

 

Historical Records

Categories